Publication date: Jul 01, 2025
Questions remain about how best to focus surveillance efforts for COVID-19 and other emerging respiratory diseases. We used an archive of COVID-19 data in Colorado from October 2020 to March 2024 to reconstruct seven real-time surveillance indicators. We assessed how well the indicators predicted 7-day average COVID-19 hospital admissions, a key indicator of outbreak severity, using machine learning and regression models, and used cross-correlation analysis to identify leading indicators. We found that hospital-based surveillance metrics, including real-time hospital census data and emergency-department based syndromic surveillance, were among the best predictors of COVID-19 hospital admissions during and after the public health emergency (PHE). While wastewater was a weaker individual predictor, its removal from our multi-indicator models resulted in a decrease in model performance, suggesting that wastewater provides important, unique information. Likewise, we found that test positivity, while imprecise, can serve as a leading indicator of COVID-19 hospitalizations. These findings suggest hospital-based reporting should be a surveillance priority, and that wastewater surveillance and test positivity can improve situational awareness for COVID-19 in Colorado. In contrast, case reporting was not found to be essential to real-time monitoring of COVID-19 hospitalizations in Colorado. The generalizability to other regions and respiratory illnesses warrants further investigation.

Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | COVID-19 |
| disease | MESH | emergency |
| disease | MESH | respiratory diseases |
| drug | DRUGBANK | L-Phenylalanine |
| disease | MESH | Long Covid |
| disease | MESH | Infectious disease |
| pathway | REACTOME | Infectious disease |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | virus shedding |
| disease | MESH | infections |
| disease | MESH | asymptomatic infections |
| disease | MESH | respiratory infections |
| disease | IDO | process |
| disease | IDO | symptom |
| drug | DRUGBANK | Flunarizine |
| disease | IDO | algorithm |
| drug | DRUGBANK | Aspartame |
| drug | DRUGBANK | Ranitidine |
| disease | MESH | morbidity |
| disease | MESH | influenza |
| drug | DRUGBANK | Water |
| drug | DRUGBANK | Abacavir |
| drug | DRUGBANK | Acetylcholine |
| pathway | REACTOME | Reproduction |